A naturalistic 6-year follow-up study of patients with panic disorder

Acta Psychiatrica Scandinavica

Volumn 93, Issue 3, 1996, Pages 181-183

  Lepola, U ^a,b   Koponen, H ^a   Leinonen, E ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Kuopio Psychiatric Research Clinic   (Finland)

Author keywords

alprazolam; depression; imipramine; panic disorder

Indexed keywords

ALPRAZOLAM; IMIPRAMINE;

ADULT; ALCOHOLISM; ANXIETY; ARTICLE; DEPRESSION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PANIC; PRIORITY JOURNAL; SUICIDAL BEHAVIOR;

EID: 0029930067     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb10628.x     Document Type: Article

References (19)

1. BARLOW DH. Cognitive-behavioral approaches to panic disorder and social phobia. Bull Menninger Clinic 56 1992: (Suppl A): A14-A28.
2. POLLACK MH, OTTO MW, ROSENBAUM JF et al. Longitudinal course of panic disorder: findings from the Massachusetts general hospital naturalistic study. J Clin Psychiatry 1990: 51 (12, suppl A): 12-16.
3. NOYES R, GARVEY MJ, COOK BL. Follow-up study of patients with agoraphobia treated with tricyclics. J Affect Disord 1989: 16: 249-257.
4. NOYES R, REICH J, CRISTIANSEN J. Outcome of panic disorder: relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 1990: 47: 809-818.
5. KATSCHNIG H, STOLK JM, KLERMAN GL. Discontinuation and long-term follow-up of participants in a clinical drug trial for panic disorder. Biol Psychiatry 1991: 31: 657-660.
6. LEPOLA UM, RIMON RH, RIEKKINEN PJ. Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine. Int J Clin Psychopharmacol 1993: 8: 115-118.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 3rd Edn., revised. Washington, DC: American Psychiatric Association, 1987.
8. HAMILTON MA. The assessment of anxiety states by rating. Br J Med Psychol 1959: 32: 50-55.
9. MONTGOMERY SA, ÅSBERG M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979: 134: 382-389.
10. DEROGATIS LR, LIPMAN RS, COVI L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 1973: 9: 13-28.
11. LEPOLA U. Panic disorder. A clinical, neurochemical, neurophysiological and neuroradiological study. Kuopio: University of Kuopio, (Thesis) 1990.
12. WEISSMAN MM, KLERMAN GL, MARKOWITZ JS, OUELLETTE R. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989: 321: 1209-1214.
13. LEPINE JP, CHIGNON JM, TEHERANI M. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry 1993: 50: 144-149.
14. ISOMETSÄ ET, HENRIKSON MM, ARO HM, HEIKKINEN ME, KUOPPASALMI KI, LÖNNQVIST JK. Suicide in major depression. Am J Psychiatry 1994: 151: 530-536.
15. HUMBLE M, WISTEDT B. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. Int J Clin Psychopharmacol 1992: 6 (suppl 5): 21-39.
16. LEPOLA U, LEINONEN E, TURTONEN J, PENTTINEN J. The effect of citalopram in panic disorder and agoraphobia. A pilot study. Nord J Psychiatry 1994: 48: 13-17.
17. DUPONT RL. Thinking about stopping treatment for panic disorder. J Clin Psychiatry 1990: 51 (12, Suppl. A): 38-45.
18. BRIGGS AC, STRETCH DD, BRANDON S. Subtyping of panic disorder by symptom profile. Br J Psychiatry 1993: 163: 201-209.
19. RICKELS K, SCHWEIZER E, WEISS S, ZAVODNICK S. Maintenance drug treatment for panic disorder. II. Short-and long-term outcome after drug taper. Arch Gen Psychiatry 1993: 50: 61-68.